Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Zanon

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Molecular Oncology|September 24, 2017
Transcription instability in high-risk neuroblastoma is associated with a global perturbation of chromatin domainsCarlo Zanon, Gian Paolo Tonini
Pharmacology & Therapeutics|February 1, 2020
A BAG's life: Every connection matters in cancerElena Mariotto, Giampietro Viola, Carlo Zanon, et al.
Oncotarget|January 7, 2016
Combating autophagy is a strategy to increase cytotoxic effects of novel ALK inhibitor entrectinib in neuroblastoma cellsSanja Aveic, Marcella Pantile, Anke Seydel, et al.
Materials Today. Bio|March 13, 2023
3D geometry orchestrates the transcriptional landscape of metastatic neuroblastoma cells in a multicellular <i>in vitro</i> bone modelRamin Nasehi, Ali T Abdallah, Marcella Pantile, et al.
Cancer Research|March 17, 2007
Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapiesSilvia Benvenuti, Andrea Sartore-Bianchi, Federica Di Nicolantonio, et al.
Advanced Biology|July 18, 2025
LIN28B Promotes Cancer Cell Dissemination and AngiogenesisDiana Corallo, Sara Menegazzo, Marcella Pantile, et al.
Oncotarget|April 16, 2016
Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinomaEdoardo D'Angelo, Matteo Fassan, Isacco Maretto, et al.
Journal of Clinical Pathology|September 6, 2017
miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinomaEdoardo D'Angelo, Carlo Zanon, Francesca Sensi, et al.
Pediatric Blood & Cancer|October 2, 2019
Next-generation sequencing of PTEN mutations for monitoring minimal residual disease in T-cell acute lymphoblastic leukemiaGiuseppe Germano, Maria Grazia Valsecchi, Barbara Buldini, et al.
Human Mutation|November 21, 2007
PIK3CA cancer mutations display gender and tissue specificity patternsSilvia Benvenuti, Milo Frattini, Sabrina Arena, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Molecular Oncology|September 24, 2017
Transcription instability in high-risk neuroblastoma is associated with a global perturbation of chromatin domainsCarlo Zanon, Gian Paolo Tonini
Pharmacology & Therapeutics|February 1, 2020
A BAG's life: Every connection matters in cancerElena Mariotto, Giampietro Viola, Carlo Zanon, et al.
Oncotarget|January 7, 2016
Combating autophagy is a strategy to increase cytotoxic effects of novel ALK inhibitor entrectinib in neuroblastoma cellsSanja Aveic, Marcella Pantile, Anke Seydel, et al.
Materials Today. Bio|March 13, 2023
3D geometry orchestrates the transcriptional landscape of metastatic neuroblastoma cells in a multicellular <i>in vitro</i> bone modelRamin Nasehi, Ali T Abdallah, Marcella Pantile, et al.
Cancer Research|March 17, 2007
Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapiesSilvia Benvenuti, Andrea Sartore-Bianchi, Federica Di Nicolantonio, et al.
Advanced Biology|July 18, 2025
LIN28B Promotes Cancer Cell Dissemination and AngiogenesisDiana Corallo, Sara Menegazzo, Marcella Pantile, et al.
Oncotarget|April 16, 2016
Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinomaEdoardo D'Angelo, Matteo Fassan, Isacco Maretto, et al.
Journal of Clinical Pathology|September 6, 2017
miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinomaEdoardo D'Angelo, Carlo Zanon, Francesca Sensi, et al.
Pediatric Blood & Cancer|October 2, 2019
Next-generation sequencing of PTEN mutations for monitoring minimal residual disease in T-cell acute lymphoblastic leukemiaGiuseppe Germano, Maria Grazia Valsecchi, Barbara Buldini, et al.
Human Mutation|November 21, 2007
PIK3CA cancer mutations display gender and tissue specificity patternsSilvia Benvenuti, Milo Frattini, Sabrina Arena, et al.
Pageof 5